HOME >> MEDICINE >> NEWS
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries

han the European average in the USA and three times higher in Germany. Uptake in Australia, the UK, Norway and Poland was low. For pemetrexed, France and the USA had a high uptake and Canada, Czech Republic, New Zealand, Poland and the UK had a low uptake.

Dr Wilking said: "Progress in medical treatments has meant that over half of the patients diagnosed with cancer will now be 'cured' or die from other causes. However, these benefits are only realised once the drugs get to the patients. Our report highlights that in many countries new drugs are not reaching patients quickly enough and that this is having an adverse impact on patient survival. Where you live can determine whether you receive the best available treatment or not. To some extent this is determined by economic factors, but much of the variation between countries remains unexplained.

"In the US we have found that the survival of cancer patients is significantly related to the introduction of new oncology drugs. From a European perspective, we have found differences in access reflected in patient outcome in the five major western European countries: France, Germany, Italy, Spain and the UK."

Of these five European countries, France had the highest five-year survival rate for all cancers (apart from non-melanoma skin cancer): 71% for women and 53% for men. Spain had five-year survival rates of 64% and 50% respectively, in Germany it was 63% and 53%, in Italy 63% and 48%, and the UK had the lowest at 53% and 43% respectively. The report also shows that in France, Spain, Germany and Italy 51-52% of cancer patients were treated with drugs launched after 1985, but only 40% of patients in the UK had access to these drugs.

Dr Jnsson said: "Around one sixth of the differences between these five countries in five-year cancer survival is due to differences in the uptake of new drugs in each country."

Two other analyses in the report also related access to new canc
'"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
European Society for Medical Oncology
9-May-2007


Page: 1 2 3 4

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Comparison of 4 diet plans shows better outcomes for diet with lowest carbohydrate intake
3. Comparison of drug-releasing coronary stents show similar effectiveness
4. Hepatitis B patients understanding of infection and treatment deficient
5. Alzheimers weight gain initiative also improved patients intellectual abilities
6. Referral management schemes damage patients interests
7. Blood transfusions raise heart patients infection and death risk -- especially women
8. New UF tool measures heart implant patients anxiety
9. New research addresses taboos around the impact of rheumatoid arthritis on patients sex lives
10. Secret herb in tests to stop breast cancer patients hot flushes and night sweats
11. Internet research builds cancer patients confidence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
Breaking Medicine Technology:
Cached News: